Northern Trust
CVRX icon

Northern Trust’s CVRx CVRX Stock Holding History

Northern Trust’s Portfolio CVRX Stock Details CVRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$641K Sell
124,767
-25,356
-17% -$164K ﹤0.01% 3602
2026
Q1 		$1.42M Buy
150,123
+12,314
+9% +$90.1K ﹤0.01% 3151
2025
Q4 		$978K Sell
137,809
-11,475
-8% -$105K ﹤0.01% 3395
2025
Q3 		$1.2M Buy
149,284
+900
+0.6% +$6.77K ﹤0.01% 3313
2025
Q2 		$872K Sell
148,384
-610
-0.4% -$4.21K ﹤0.01% 3452
2025
Q1 		$1.82M Buy
148,994
+10,111
+7% +$143K ﹤0.01% 2971
2024
Q4 		$1.76M Buy
138,883
+5,671
+4% +$70K ﹤0.01% 3099
2024
Q3 		$1.17M Buy
133,212
+37,496
+39% +$341K ﹤0.01% 3295
2024
Q2 		$1.15M Buy
95,716
+2,162
+2% +$24.9K ﹤0.01% 3185
2024
Q1 		$1.7M Sell
93,554
-1,643
-2% -$38.9K ﹤0.01% 3050
2023
Q4 		$2.99M Buy
95,197
+4,646
+5% +$87.2K ﹤0.01% 2777
2023
Q3 		$1.37M Sell
90,551
-1,818
-2% -$29.9K ﹤0.01% 3138
2023
Q2 		$1.43M Buy
92,369
+73,517
+390% +$897K ﹤0.01% 3208
2023
Q1 		$176K Hold
18,852
– – ﹤0.01% 3909
2022
Q4 		$346K Buy
18,852
+3,740
+25% +$46.2K ﹤0.01% 3628
2022
Q3 		$141K Buy
15,112
+3,283
+28% +$26K ﹤0.01% 4004
2022
Q2 		$71K Sell
11,829
-79,104
-87% -$455K ﹤0.01% 4297
2022
Q1 		$544K Buy
90,933
+13,674
+18% +$110K ﹤0.01% 3702
2021
Q4 		$945K Buy
77,259
+3,557
+5% +$51.6K ﹤0.01% 3560
2021
Q3 		$1.22M Buy
+73,702
New +$1.41M ﹤0.01% 3488

Other funds holding CVRX

Johnson & Johnson
Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return
NEA Management Company
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
GSK plc
GSK plc London $602M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Silvercrest Asset Management
Silvercrest Asset Management New York $15.3B AUM 40.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
PFM Health Sciences
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Northern Trust's CVRX Position: Q2 2026 in Review

Northern Trust reduced its CVRx (CVRX) stake by 17% in Q2 2026, selling an estimated $164K and leaving 124,767 shares worth $641K. The position accounts for ﹤0.01% of the portfolio, ranked #3602.

Northern Trust first reported a position in CVRX in Q3 2021 and has held it in 20 quarters since. The position peaked at $2.99M in Q4 2023. 87 funds tracked by Wall St. Rank hold CVRX as of Q2 2026.

  • Northern Trust held 124,767 shares of CVRx worth $641K as of Q2 2026.
  • Northern Trust sold 25,356 CVRx shares in Q2 2026, an estimated $164K.
  • CVRx made up ﹤0.01% of Northern Trust's portfolio in Q2 2026, its #3602 holding.
  • Northern Trust first reported a position in CVRx in Q3 2021 and has held it in 20 quarters since.
  • Northern Trust's CVRx position peaked at $2.99M in Q4 2023.
  • 87 funds tracked by Wall St. Rank held CVRx as of Q2 2026.

Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.